Minoryx Therapeutics

Minoryx Therapeutics is a private VC-backed company developing innovative therapies for the treatment of orphan CNS (central nervous system) diseases. The molecule MIN-102 is currently in a pivotal Phase 2/3 study for life threatening, orphan chronic subtype adrenomyeloneuropathy (AMN, adult form of X-ALD) and in a Phase 2 study for Friedrich’s Ataxia (FRDA); top line data for both expected by end of 2020 and marketing authorization filing in US/EU will follow. The company was founded in 2011, raised €50m so far and has operations in Spain and Belgium.

Barré SA

Barré SA est active en clean piping, filtration d'air et production métalliques (pièces à façon) à haute technologie pour le secteur pharmaceutique et les sciences du vivant. La société est un spécialiste des unités de production de niveau FDA.

Korvis Europe

Korvis designs and manufactures, in volume, complex machinery and instruments. We provide our customers with tested product, ready to ship to the end user. Our manufacturing services include value engineering and cost cutting manufacturing techniques. Korvis' unique blend of product design and contract manufacturing lowers the overall product cost to its customers.

Probare AB

ProbarE AB conduct clinical trials for drugs that are under development.

We have extensive experience within several medical specialities and a solid track record in conducting clinical trials successfully.

We have had nineteen audits – where sponsors / pharmaceutical companies carefully monitor and control the current and completed studies. We have also had two inspections from the MPA.

HealthCare Consulting (HCC)

Are you wishing to develop and launch innovative medical products?
HealthCare Consulting (HCC)'s mission is to set you up for successful Market Access and Commercialisation in France and the Benelux region! 

HCC offers a highly personalised approach and provides solutions across all aspects of market access. 

Actavia

Actavia propose un concept disruptif dans le monde du consulting. Tous ses membres ont occupé des postes de Direction générale et couvrent des secteurs variés, avec une prédilection pour le healthcare, l'innovation et la transformation digitale. Présents depuis 8 à 15 ans en Asie, ses associés ont construit un écosystème dans la région qui fait d'Actavia la porte d'entrée idéale pour votre stratégie de développement en Asie.

UCB Pharma

UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

PDC Line Pharma

PDC*line Pharma is a clinical-stage biotech company that develops a new class of antigen – specific active immunotherapies based on a proprietary allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line).
S'abonner à Immunologie